(Nasdaq: TRNS) ("Transcat" or the "Company"), a leader in test measurement, control and calibration, today announced the approval of one-time equity retention awards for certain executive officers.
Siemens highlighted its long-standing partnership with Nvidia at CES 2026 as the two firms develop the Industrial AI ...
At CES 2026, Siemens’ keynote marked a new era of technology for industry and infrastructure, showcasing how customers and ...
GlobalData on MSN
FDA announces regulatory exemptions for ‘non-medical grade’ devices
FDA commissioner Marty Makary revealed at the 2026 CES trade show in Las Vegas that low-risk devices will face less ...
New artificial intelligence-enabled health wearable devices and clinical decision support software will not face U.S. Food and Drug Administration regulatory ...
Tuesday, January 6, 2026, yielded two surprising updates from the Food and Drug Administration (“FDA”) Center for Devices and Radiological Health. While many experts have been forecasting continued ...
As artificial intelligence tools increasingly enter gastrointestinal medicine, a team of international experts led by Tyler M ...
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback